{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T17:10:09Z","timestamp":1744045809966,"version":"3.40.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The goal of this work is to investigate the sociodemographic characteristics and health status of women with breast cancer (BC) in association with COVID-19 by menopausal status. In a Swedish register-based cross-sectional study, we compared women with BC and with or without a positive COVID-19 test, stratified by menopausal status (age\u2009\u2265\u200951 years). Socioeconomic characteristics and health status (represented by diagnoses registered in 5 years- and prescription dispensed in 2 years preceding Jan 2020) were considered in association with COVID-19 diagnosis. The study population included 38,523 women with BC. Median age at BC diagnosis was 45 years (IQR\u2009=\u200940\u201348) for premenopausal- and 67 (IQR\u2009=\u200960\u201373) for postmenopausal BC. A logistic regression model was used and found the significant covariate effects (adjusted odds ratios, ORs) for a positive COVID-19 test among women with premenopausal BC to be being born outside of Europe: 1.29, (1.13\u20131.46), being married: 1.23, (1.12\u20131.36), being unemployed 1.92 (1.59\u20132.30), having upper secondary school education 1.25 (1.01\u20131.54), having\u2009&gt;\u200915 outpatient visits: 1.31, (1.07\u20131.61), and a history of being admitted to hospital 1\u20135 times: 1.12 (1.01\u20131.25). Corresponding significant covariate effects among women with postmenopausal BC were being born outside of Europe: 1.61 (1.41\u20131.83), being married: 1.12 (1.04\u20131.21), and being unemployed 1.54 (1.40\u20131.69). Postmenopausal women furthermore had more outpatient visits or hospital admissions before the pandemic in COVID-19 positive patients compared to patients without a COVID-19 positive test, e.g.  1.47 (1.26\u20131.71) for &gt;\u200915 outpatient visits compared with no visit and 6.35 (3.33\u201312.11) for &gt;\u200915 hospital admissions compared with no admission. Varied socioeconomical and clinical conditions were more frequent among patients with a positive COVID-19 test compared to patients without a positive test among women with BC in pre- or post-menopausal status. We conclude that some characteristics of women such as unemployment, country of birth or health status measured by number of prescribed drugs were more prevalent among women who developed COVID-19 compared to women without COVID-19 diagnosis and either of menopausal status of breast cancer.<\/jats:p>","DOI":"10.1038\/s41598-025-86710-8","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T11:14:52Z","timestamp":1737458092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sociodemographic characteristics and health status of women with breast cancer and COVID 19 diagnosis by menopausal status a cross sectional study"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8118-4988","authenticated-orcid":false,"given":"Mohammadhossein","family":"Hajiebrahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3912-0267","authenticated-orcid":false,"given":"Hussam","family":"Shihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-9445","authenticated-orcid":false,"given":"Ola","family":"Bratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-0829","authenticated-orcid":false,"given":"Huiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0892-5668","authenticated-orcid":false,"given":"Fredrik","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0531-2516","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Wettermark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"86710_CR1","unstructured":"Coronavirus disease (COVID-19). pandemic. https:\/\/www.who.int\/europe\/emergencies\/situations\/covid-19"},{"key":"86710_CR2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bpa.2020.11.009","volume":"35","author":"AD Kaye","year":"2021","unstructured":"Kaye, A. D. et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Pract. Res. Clin. Anaesthesiol. 35, 293\u2013306 (2021).","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"86710_CR3","doi-asserted-by":"crossref","first-page":"e045343","DOI":"10.1136\/bmjopen-2020-045343","volume":"11","author":"R Moynihan","year":"2021","unstructured":"Moynihan, R. et al. Impact of COVID-19 pandemic on utilisation of healthcare services: A systematic review. BMJ Open. 11, e045343 (2021).","journal-title":"BMJ Open."},{"key":"86710_CR4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/GO.20.00225","volume":"6","author":"VG Giannakoulis","year":"2020","unstructured":"Giannakoulis, V. G., Papoutsi, E. & Siempos, I. I. Effect of Cancer on clinical outcomes of patients with COVID-19: A meta-analysis of patient data. JCO Glob Oncol. 6, 799\u2013808 (2020).","journal-title":"JCO Glob Oncol."},{"key":"86710_CR5","doi-asserted-by":"crossref","first-page":"e21487","DOI":"10.1097\/MD.0000000000021487","volume":"99","author":"Z Sheng","year":"2020","unstructured":"Sheng, Z. et al. Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis. Med. (Baltim). 99, e21487 (2020).","journal-title":"Med. (Baltim)."},{"key":"86710_CR6","unstructured":"Cancer. https:\/\/www.who.int\/health-topics\/cancer"},{"key":"86710_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"Cancer J. Clin."},{"key":"86710_CR8","unstructured":"Statistik om cancer. Cancerfonden https:\/\/www.cancerfonden.se\/om-cancer\/statistik"},{"key":"86710_CR9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/jnci\/djj295","volume":"98","author":"WF Anderson","year":"2006","unstructured":"Anderson, W. F. & Matsuno, R. Breast Cancer heterogeneity: A mixture of at least two main types? JNCI: J. Natl. Cancer Inst. 98, 948\u2013951 (2006).","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"86710_CR10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrclinonc.2012.102","volume":"9","author":"SA Narod","year":"2012","unstructured":"Narod, S. A. Breast cancer in young women. Nat. Rev. Clin. Oncol. 9, 460\u2013470 (2012).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"86710_CR11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.2001.19.1.18","volume":"19","author":"WF Anderson","year":"2001","unstructured":"Anderson, W. F., Chu, K. C., Chatterjee, N., Brawley, O. & Brinton, L. A. Tumor variants by hormone receptor expression in White patients with node-negative breast Cancer from the Surveillance, Epidemiology, and end results database. JCO 19, 18\u201327 (2001).","journal-title":"JCO"},{"key":"86710_CR12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.canrad.2021.06.015","volume":"26","author":"S Allali","year":"2022","unstructured":"Allali, S., Beddok, A. & Kirova, Y. Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients? Cancer Radiother. 26, 491\u2013493 (2022).","journal-title":"Cancer Radiother"},{"key":"86710_CR13","doi-asserted-by":"crossref","first-page":"pkaa102","DOI":"10.1093\/jncics\/pkaa102","volume":"5","author":"BP Venkatesulu","year":"2021","unstructured":"Venkatesulu, B. P. et al. A systematic review and Meta-analysis of Cancer patients affected by a Novel Coronavirus. JNCI Cancer Spectr. 5, pkaa102 (2021).","journal-title":"JNCI Cancer Spectr."},{"key":"86710_CR14","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","volume":"395","author":"NM Kuderer","year":"2020","unstructured":"Kuderer, N. M. et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet 395, 1907\u20131918 (2020).","journal-title":"Lancet"},{"key":"86710_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1389201023666220421133311","volume":"24","author":"MC Stipp","year":"2023","unstructured":"Stipp, M. C., Corso, C. R. & Acco, A. Impacts of COVID-19 in breast Cancer: From molecular mechanism to the Treatment Approach. Curr. Pharm. Biotechnol. 24, 238\u2013252 (2023).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"86710_CR16","first-page":"575","volume":"21","author":"HS Parmar","year":"2021","unstructured":"Parmar, H. S. et al. Cross talk between COVID-19 and breast cancer. Curr. Cancer Drug Targets. 21, 575\u2013600 (2021).","journal-title":"Curr. Cancer Drug Targets"},{"key":"86710_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-020-01293-8","volume":"22","author":"P Vuagnat","year":"2020","unstructured":"Vuagnat, P. et al. COVID-19 in breast cancer patients: A cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Res. 22, 55 (2020).","journal-title":"Breast Cancer Res."},{"key":"86710_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.puhe.2020.09.016","volume":"189","author":"RB Hawkins","year":"2020","unstructured":"Hawkins, R. B., Charles, E. J. & Mehaffey, J. H. Socio-economic status and COVID-19-related cases and fatalities. Public. Health. 189, 129\u2013134 (2020).","journal-title":"Public. Health"},{"key":"86710_CR19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12939-021-01582-4","volume":"20","author":"A Khanijahani","year":"2021","unstructured":"Khanijahani, A., Iezadi, S., Gholipour, K., Azami-Aghdash, S. & Naghibi, D. A systematic review of racial\/ethnic and socioeconomic disparities in COVID-19. Int. J. Equity Health. 20, 248 (2021).","journal-title":"Int. J. Equity Health"},{"key":"86710_CR20","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/cancers13071514","volume":"13","author":"SF Lee","year":"2021","unstructured":"Lee, S. F., Nik\u0161i\u0107, M., Rachet, B., Sanchez, M. J. & Luque-Fernandez, M. A. Socioeconomic inequalities and ethnicity are associated with a positive COVID-19 test among cancer patients in the UK Biobank Cohort. Cancers (Basel). 13, 1514 (2021).","journal-title":"Cancers (Basel)"},{"key":"86710_CR21","doi-asserted-by":"crossref","first-page":"eabg5298","DOI":"10.1126\/science.abg5298","volume":"372","author":"GE Mena","year":"2021","unstructured":"Mena, G. E. et al. Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science 372, eabg5298 (2021).","journal-title":"Science"},{"key":"86710_CR22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s12282-022-01352-2","volume":"29","author":"P Monsivais","year":"2022","unstructured":"Monsivais, P. et al. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: Analysis of two cohorts of women 50 years +. Breast Cancer. 29, 740\u2013746 (2022).","journal-title":"Breast Cancer"},{"key":"86710_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/1078-0432.CCR-20-3421","volume":"27","author":"LA Newman","year":"2021","unstructured":"Newman, L. A., Winn, R. A. & Carethers, J. M. Similarities in risk for COVID-19 and Cancer disparities. Clin. Cancer Res. 27, 24\u201327 (2021).","journal-title":"Clin. Cancer Res."},{"key":"86710_CR24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/0284186X.2021.1934536","volume":"60","author":"P Strang","year":"2021","unstructured":"Strang, P., Hedman, C., Adlitzer, H. & Schultz, T. Dying from cancer with COVID-19: Age, sex, socio-economic status, and comorbidities. Acta Oncol. 60, 1019\u20131024 (2021).","journal-title":"Acta Oncol."},{"key":"86710_CR25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2147\/CLEP.S312742","volume":"13","author":"F Nyberg","year":"2021","unstructured":"Nyberg, F. et al. Swedish Covid-19 investigation for future insights \u2013 A population epidemiology approach using register linkage (SCIFI-PEARL). CLEP Volume. 13, 649\u2013659 (2021).","journal-title":"CLEP Volume"},{"key":"86710_CR26","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer, E. et al. Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study. Lancet Global Health. 8, e1027\u2013e1037 (2020).","journal-title":"Lancet Global Health"},{"key":"86710_CR27","doi-asserted-by":"publisher","unstructured":"Kaczmarek, M. Variation in age at natural menopause among Polish women in relation to Biological and Social factors. 119\u2013142 https:\/\/doi.org\/10.13140\/2.1.2610.1449 (2014).","DOI":"10.13140\/2.1.2610.1449"},{"key":"86710_CR28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","volume":"34","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson, J. F., Svedberg, P., Ol\u00e9n, O., Bruze, G. & Neovius, M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur. J. Epidemiol. 34, 423\u2013437 (2019).","journal-title":"Eur. J. Epidemiol."},{"key":"86710_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2807\/esm.11.05.00626-en","volume":"11","author":"P Rolfhamre","year":"2006","unstructured":"Rolfhamre, P., Jansson, A., Arneborn, M. & Ekdahl, K. SmiNet-2: Description of an internet-based surveillance system for communicable diseases in Sweden. Euro. Surveill. 11, 103\u2013107 (2006).","journal-title":"Euro. Surveill"},{"key":"86710_CR30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark, B. et al. The new Swedish prescribed drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidem Drug Safe. 16, 726\u2013735 (2007).","journal-title":"Pharmacoepidem Drug Safe"},{"key":"86710_CR31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson, J. F. et al. External review and validation of the Swedish national inpatient register. BMC Public. Health. 11, 450 (2011).","journal-title":"BMC Public. Health"},{"key":"86710_CR32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.rceng.2020.10.005","volume":"221","author":"C Guijarro","year":"2021","unstructured":"Guijarro, C. et al. Differential risk for COVID-19 in the first wave of the disease among spaniards and migrants from different areas of the world living in Spain. Revista Cl\u00ednica Espa\u00f1ola (English Edition). 221, 264\u2013273 (2021).","journal-title":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)"},{"key":"86710_CR33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1403494820984026","volume":"49","author":"T Indseth","year":"2021","unstructured":"Indseth, T. et al. COVID-19 among immigrants in Norway, notified infections, related hospitalizations and associated mortality: A register-based study. Scand. J. Public. Health. 49, 48\u201356 (2021).","journal-title":"Scand. J. Public. Health"},{"key":"86710_CR34","doi-asserted-by":"crossref","first-page":"e2026881","DOI":"10.1001\/jamanetworkopen.2020.26881","volume":"3","author":"G Ogedegbe","year":"2020","unstructured":"Ogedegbe, G. et al. Assessment of Racial\/Ethnic disparities in hospitalization and mortality in patients with COVID-19 in New York City. JAMA Netw. Open. 3, e2026881 (2020).","journal-title":"JAMA Netw. Open."},{"key":"86710_CR35","unstructured":"Breast cancer statistics | World Cancer Research Fund International. WCRF Int. Accessed 8 Aug 2023. https:\/\/www.wcrf.org\/cancer-trends\/breast-cancer-statistics\/"},{"key":"86710_CR36","unstructured":"Categories of Essential Workers. COVID-19 Vaccination | CDC. (2023). https:\/\/www.cdc.gov\/vaccines\/covid-19\/categories-essential-workers.html"},{"key":"86710_CR37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/jech-2021-218278","volume":"76","author":"CA Nwaru","year":"2022","unstructured":"Nwaru, C. A., Santosa, A., Franz\u00e9n, S. & Nyberg, F. Occupation and COVID-19 diagnosis, hospitalisation and ICU admission among foreign-born and Swedish-born employees: A register-based study. J. Epidemiol. Community Health. 76, 440\u2013447 (2022).","journal-title":"J. Epidemiol. Community Health"},{"key":"86710_CR38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/oemed-2020-106731","volume":"78","author":"M Mutambudzi","year":"2021","unstructured":"Mutambudzi, M. et al. Occupation and risk of severe COVID-19: Prospective cohort study of 120,075 UK Biobank participants. Occup. Environ. Med. 78, 307\u2013314 (2021).","journal-title":"Occup. Environ. Med."},{"key":"86710_CR39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/fampra\/cms060","volume":"30","author":"SL Brilleman","year":"2013","unstructured":"Brilleman, S. L. & Salisbury, C. Comparing measures of multimorbidity to predict outcomes in primary care: A cross sectional study. Fam. Pract. 30, 172\u2013178 (2013).","journal-title":"Fam. Pract."},{"key":"86710_CR40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/fampra\/cmaa056","volume":"38","author":"T Forslund","year":"2021","unstructured":"Forslund, T., Carlsson, A. C., Ljunggren, G., \u00c4rnl\u00f6v, J. & Wachtler, C. Patterns of multimorbidity and pharmacotherapy: A total population cross-sectional study. Fam. Pract. 38, 132\u2013140 (2021).","journal-title":"Fam. Pract."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86710-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T16:49:17Z","timestamp":1744044557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86710-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86710"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86710-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethical Review Authority (2020\u2009\u2212\u200901800 with subsequent amendments).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Since this was a register-based observational study the Swedish Ethical Review Authority waived informed consent, as normally done for this type of study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved the final version for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"2648"}}